Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 8, 2013, Pages 1751-1760

  Wu, Kaijie ^a,b   Zeng, Jin ^a,b   Zhou, Jiancheng ^a,b   Fan, Jinhai ^a   Chen, Yule ^a,b   Wang, Zhiqiang ^a,b   Zhang, TingTing ^a,b   Wang, Xinyang ^b   He, Dalin ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Bladder cancer; Chemoresistance; Epithelial to mesenchymal transition; Invasion; Slug

Indexed keywords

BETA CATENIN; CASPASE 3; CASPASE 9; CYTOKERATIN 18; CYTOKERATIN 19; FIBRONECTIN; GELATINASE A; GELATINASE B; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR SLUG; UVOMORULIN; VIMENTIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL INVASION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MUSCLE INVASIVE BLADDER CANCER; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

BLADDER CANCER; CHEMORESISTANCE; EPITHELIAL-TO-MESENCHYMAL TRANSITION; INVASION; SLUG;

APOPTOSIS; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTORS; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 84886278395     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.02.001     Document Type: Article

References (41)

1. Ploeg M., Aben K.K., Kiemeney L.A. The present and future burden of urinary bladder cancer in the world. World J Urol 2009, 27:289-293.
2. van Rhijn B.W., Burger M., Lotan Y., et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy. Eur Urol 2009, 56:430-442.
3. Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005, 48:202-206. Advanced Bladder Cancer (ABC) Meta-Analysis Collaboration.
4. Bryan R.T., Tselepis C. Cadherin switching and bladder cancer. J Urol 2010, 184:423-431.
5. Bryan R.T., Atherfold P.A., Yeo Y., et al. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: Ex vivo and in vitro studies. J Pathol 2008, 215:184-194.
6. Lascombe I., Clairotte A., Fauconnet S., et al. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res 2006, 12:2780-2787.
7. Thiery J.P., Acloque H., Huang R.Y., et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
8. Acloque H., Adams M.S., Fishwick K., et al. Epithelial-mesenchymal transitions: The importance of changing cell state in development and disease. J Clin Invest 2009, 119:1438-1449.
9. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009, 119:1429-1437.
10. McConkey D.J., Choi W., Marquis L., et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009, 28:335-344.
11. Baumgart E., Cohen M.S., Silva Neto B., et al. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 2007, 13:1685-1694.
12. Adam L., Zhong M., Choi W., et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 2009, 15:5060-5072.
13. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumor progression: An alliance against the epithelial phenotype?. Nat Rev Cancer 2007, 7:415-428.
14. Moreno-Bueno G., Portillo F., Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008, 27:6958-6969.
15. De Craene B., van Roy F., Berx G. Unraveling signalling cascades for the snail family of transcription factors. Cell Signal 2005, 17:535-547.
16. Alves C.C., Carneiro F., Hoefler H., et al. Role of the epithelial-mesenchymal transition regulator slug in primary human cancers. Front Biosci 2009, 14:3035-3050.
17. Karam J.A., Huang S., Fan J., et al. Upregulation of TRAG3 gene in urothelial carcinoma of the bladder. Int J Cancer 2010, 128:2823-2832.
18. Zhang T., Fan J., Wu K., et al. Roles of HIF-1α in a novel optical orthotopic spontaneous metastatic bladder cancer animal model. Urol Oncol 2012 Feb 14, [Epub ahead of print].
19. Zhu G., Zhau H.E., He H., et al. Sonic and Desert hedgehog signaling in human fetal prostate development. Prostate 2007, 67:674-684.
20. Xie D., Gore C., Zhou J., et al. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proc Natl Acad Sci U S A 2009, 106:19878-19883.
21. Shih J.Y., Tsai M.F., Chang T.H., et al. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin Cancer Res 2005, 11:8070-8078.
22. Wu K., Zeng J., Li L., et al. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors. Oncol Rep 2010, 23:1545-1552.
23. Zeng J., Sun Y., Wu K., et al. Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria. Mol Cancer Ther 2011, 10:104-116.
24. Dyrskjøt L., Kruhøffer M., Thykjaer T., et al. Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 2004, 64:4040-4048.
25. Jäger T., Becker M., Eisenhardt A., et al. The prognostic value of cadherin switch in bladder cancer. Oncol Rep 2010, 23:1125-1132.
26. Shioiri M., Shida T., Koda K., et al. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer 2006, 94:1816-1822.
27. Elloul S., Silins I., Tropé C.G., et al. Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch 2006, 449:520-528.
28. Storci G., Sansone P., Trere D., et al. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol 2008, 214:25-37.
29. Yang H.W., Menon L.G., Black P.M., et al. SNAI2/slug promotes growth and invasion in human gliomas. BMC Cancer 2010, 10:301.
30. Mancini M., Petta S., Iacobucci I., et al. Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. Cell Signal 2010, 22:1247-1253.
31. Bruyere F., Namdarian B., Corcoran N.M., et al. Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers. Urol Oncol 2010, 28:591-596.
32. Cobaleda C., Pérez-Caro M., Vicente-Dueñas C., et al. Function of the zinc-finger transcription factor SNAI2 in cancer and development. Annu Rev Genet 2007, 41:41-61.
33. Mani S.A., Guo W., Liao M.J., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
34. Pérez-Losada J., Sánchez-Martín M., Rodríguez-García A., et al. Zinc-finger transcription factor slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood 2002, 100:1274-1286.
35. Storci G., Sansone P., Mari S., et al. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol 2010, 225:682-691.
36. McConkey D.J., Lee S., Choi W., et al. Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression. Urol Oncol 2010, 28:429-440.
37. Sayan A.E., Griffiths T.R., Pal R., et al. SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci U S A 2009, 106:14884-14889.
38. Fondrevelle M.E., Kantelip B., Reiter R.E., et al. The expression of twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol 2009, 27:268-276.
39. Yu Q., Zhang K., Wang X., et al. Expression of transcription factors snail, slug, and twist in human bladder carcinoma. J Exp Clin Cancer Res 2010, 29:119.
40. Taube J.H., Herschkowitz J.I., Komurov K., et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 2010, 107:15449-15454.
41. Casas E., Kim J., Bendesky A., et al. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 2011, 71:245-254.